Biophysics Program News Today

Reagan institute. Ladies and gentlemen, please welcome to the stage director of the Ronald Reagan institute, mr. Roger zakheim. [applause] mr. Zakheim i appreciate it. Good morning, everybody. Thank you for joining us today at the Ronald Reagan institute. Which as those in the room no, carries on the legacy of our nations 40th president here in washington, d. C. As mentioned i am roger zakheim, director of the institute. And we are excited to host this event as part of our center for peace throu...

Reagan institute. Ladies and gentlemen, please welcome to the stage director of the Ronald Reagan institute, mr. Roger zakheim. [applause] mr. Zakheim i appreciate it. Good morning, everybody. Thank you for joining us today at the Ronald Reagan institute. Which as those in the room no, carries on the legacy of our nations 40th president here in washington, d. C. As mentioned i am roger zakheim, director of the institute. And we are excited to host this event as part of our center for peace throu...

Reagan institute. Ladies and gentlemen, please welcome to the stage director of the Ronald Reagan institute, mr. Roger zakheim. [applause] mr. Zakheim i appreciate it. Good morning, everybody. Thank you for joining us today at the Ronald Reagan institute. Which as those in the room no, carries on the legacy of our nations 40th president here in washington, d. C. As mentioned i am roger zakheim, director of the institute. And we are excited to host this event as part of our center for peace throu...

Reagan institute. Ladies and gentlemen, please welcome to the stage director of the Ronald Reagan institute, mr. Roger zakheim. [applause] mr. Zakheim i appreciate it. Good morning, everybody. Thank you for joining us today at the Ronald Reagan institute. Which as those in the room no, carries on the legacy of our nations 40th president here in washington, d. C. As mentioned i am roger zakheim, director of the institute. And we are excited to host this event as part of our center for peace throu...

Protillion Biosciences Raises $18 Million Series A Financing Led by ARCH Venture Partners and Illumina Ventures - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- Protillion Biosciences, a privately held biotech company working to identify and optimize new protein therapeutics and accelerate biologic...

The program encompasses the full range of biophysics research at Princeton, from molecules to ecosystems, including both experimental and theoretical work.

APS recognizes outstanding achievement in research, education, and public service.